Literature DB >> 17306068

[Association of a polymorphism in MDR1 C3435T with response to antiepileptic drug treatment in ethic Han Chinese children with epilepsy].

Li Chen1, Chang-Qin Liu, Yan Hu, Zhi-Tian Xiao, Yan Chen, Jian-Xiang Liao.   

Abstract

OBJECTIVE: P-glycoprotein 170 (P-gp) is a plausible biologic candidate for pharmacoresistance in epilepsy. The expression and efflux efficiency of P-gp is influenced by a polymorphism (C3435T) in the encoding gene (MDR1). The CC genotype at the MDR1 C3435T polymorphism was reported to be associated with the response to antiepileptic drug treatment. This study attempted to replicate this finding by examining the association of this genetic polymorphism with response to antiepileptic drug treatment in ethnic Han Chinese children with epilepsy.
METHODS: Two hundred and fourteen ethnic Han Chinese children with epilepsy were classified based on the response to antiepileptic drug treatment: drug-nonresponsive and drug-responsive. DNA samples were obtained from the patients. Genotypes of the C3435T polymorphism were determined by traditional polymerase chain reaction followed by restriction digestion (PCR-RFLP). The frequency of genotypes and alleles between the two groups was compared by Chi-square test.
RESULTS: Of the 214 patients, 164 were drug-responsive and 50 were drug-nonresponsive. There were no significant differences in the allele frequency and genotype frequency between the two groups.
CONCLUSIONS: There is no an association between the CC genotype or C allele at the locus of C3435T in MDR1 gene and response to antiepileptic drug treatment in ethnic Han Chinese children with epilepsy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17306068

Source DB:  PubMed          Journal:  Zhongguo Dang Dai Er Ke Za Zhi        ISSN: 1008-8830


  9 in total

1.  Associations between the C3435T polymorphism of the ABCB1 gene and drug resistance in epilepsy: a meta-analysis.

Authors:  Wei-Ping Lv; Ren-Feng Han; Zhi-Rong Shu
Journal:  Int J Clin Exp Med       Date:  2014-11-15

2.  Association of MDR1 gene C3435T polymorphism with childhood intractable epilepsy: a meta-analysis.

Authors:  Guilian Sun; Xue Sun; Limei Guan
Journal:  J Neural Transm (Vienna)       Date:  2014-02-20       Impact factor: 3.575

3.  Role of multidrug transporters in neurotherapeutics.

Authors:  Manna Jose; Sanjeev V Thomas
Journal:  Ann Indian Acad Neurol       Date:  2009-04       Impact factor: 1.383

4.  ABCB1 gene C3435T polymorphism and drug resistance in epilepsy: evidence based on 8,604 subjects.

Authors:  Shu-Xia Li; Yun-Yong Liu; Quan-Bao Wang
Journal:  Med Sci Monit       Date:  2015-03-23

5.  The roles of variants in human multidrug resistance (MDR1) gene and their haplotypes on antiepileptic drugs response: a meta-analysis of 57 studies.

Authors:  Hui Li; Bing Wang; Cheng Chang; Minghua Wu; Yun Xu; Yajun Jiang
Journal:  PLoS One       Date:  2015-03-27       Impact factor: 3.240

Review 6.  Relationship between ABCB1 3435TT genotype and antiepileptic drugs resistance in Epilepsy: updated systematic review and meta-analysis.

Authors:  Malek Chouchi; Wajih Kaabachi; Hedia Klaa; Kalthoum Tizaoui; Ilhem Ben-Youssef Turki; Lamia Hila
Journal:  BMC Neurol       Date:  2017-02-15       Impact factor: 2.474

7.  ABCB1 Polymorphisms and Drug-Resistant Epilepsy in a Tunisian Population.

Authors:  Malek Chouchi; Hedia Klaa; Ilhem Ben-Youssef Turki; Lamia Hila
Journal:  Dis Markers       Date:  2019-12-02       Impact factor: 3.434

8.  CYP3A5*3 and C3435T MDR1 polymorphisms in prognostication of drug-resistant epilepsy in children and adolescents.

Authors:  Ewa Emich-Widera; Wirginia Likus; Beata Kazek; Paweł Niemiec; Anna Balcerzyk; Aleksander L Sieroń; Iwona Zak
Journal:  Biomed Res Int       Date:  2013-08-01       Impact factor: 3.411

9.  Polymorphism of ABCB1/MDR1 C3435T in children and adolescents with partial epilepsy is due to different criteria for drug resistance - preliminary results.

Authors:  Ewa Emich-Widera; Wirginia Likus; Beata Kazek; Aleksander L Sieroń; Ksymena Urbanek
Journal:  Med Sci Monit       Date:  2014-09-16
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.